Covered recipient · General Payments record
MARK J COSSENTINO
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,727.17
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $630.54 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $489.80 | 26 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.98 | 1 |
| RedHill Biopharma Inc. | $20.18 | 1 |
| Celgene Corporation | $19.46 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.12 | 1 |
| Madrigal Pharmaceuticals | $15.04 | 1 |
| Medtronic, Inc. | $13.99 | 1 |
| Ipsen Biopharmaceuticals, Inc | $13.51 | 1 |
| SHIELD THERAPEUTICS INC | $13.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.78 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505774 | CMS |
| ABBVIE INC. | $25.54 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505776 | CMS |
| ABBVIE INC. | $18.73 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505778 | CMS |
| ABBVIE INC. | $20.56 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505780 | CMS |
| ABBVIE INC. | $4.66 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505782 | CMS |
| ABBVIE INC. | $22.36 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505784 | CMS |
| ABBVIE INC. | $18.23 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505786 | CMS |
| ABBVIE INC. | $19.34 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505788 | CMS |
| ABBVIE INC. | $11.12 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505790 | CMS |
| ABBVIE INC. | $23.76 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505792 | CMS |
| ABBVIE INC. | $8.43 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505794 | CMS |
| ABBVIE INC. | $16.07 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505796 | CMS |
| ABBVIE INC. | $17.70 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505798 | CMS |
| ABBVIE INC. | $26.76 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505800 | CMS |
| ABBVIE INC. | $23.34 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505802 | CMS |
| ABBVIE INC. | $11.10 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505804 | CMS |
| ABBVIE INC. | $10.41 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505806 | CMS |
| ABBVIE INC. | $29.92 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505808 | CMS |
| ABBVIE INC. | $14.93 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505810 | CMS |
| ABBVIE INC. | $25.11 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505812 | CMS |
| ABBVIE INC. | $12.95 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505814 | CMS |
| ABBVIE INC. | $16.57 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505816 | CMS |
| ABBVIE INC. | $34.76 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505818 | CMS |
| ABBVIE INC. | $23.37 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505820 | CMS |
| ABBVIE INC. | $20.10 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505822 | CMS |
| ABBVIE INC. | $7.20 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505824 | CMS |
| Celgene Corporation | $19.46 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101101115 | CMS |
| Ipsen Biopharmaceuticals, Inc | $13.51 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091981332 | CMS |
| Madrigal Pharmaceuticals | $15.04 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144163865 | CMS |
| Medtronic, Inc. | $13.99 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119444879 | CMS |
| RedHill Biopharma Inc. | $20.18 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095479189 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.12 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153745848 | CMS |
| SHIELD THERAPEUTICS INC | $13.46 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150154164 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.98 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137519688 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.